U.S. Multiomics Market Size & Outlook, 2023-2030
U.S. multiomics market, 2018-2030 (US$M)
Related Markets
U.S. multiomics market highlights
- The U.S. multiomics market generated a revenue of USD 1,052.1 million in 2023 and is expected to reach USD 2,901.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 15.6% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2023 | USD 1,052.1 million |
| Market revenue in 2030 | USD 2,901.4 million |
| Growth rate | 15.6% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, U.S. accounted for 44.7% of the global multiomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. multiomics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 279.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 60.26% in 2023. Horizon Databook has segmented the U.S. multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
The multiomics market in the U.S. is highly competitive due to the growing demand for comprehensive biological insights fueled by advancements in omics technologies. This competition is intensified by active R&D efforts in academia and industry, with institutions and companies vying for funding and breakthrough discoveries.
For instance, in 2023, the Keck School of Medicine at the University of Southern California (USC) secured a significant 5-year, USD 50.3 million research grant from the National Institutes of Health (NIH).
This funding will support a multiomics study conducted by a consortium of six sites, with a primary focus on investigating various health conditions, including fatty liver disease, hepatocellular carcinoma, chronic kidney disease, and asthma.
Reasons to subscribe to U.S. multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. multiomics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. multiomics market size, by product & service, 2018-2030 (US$M)
U.S. Multiomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
